Detalhe da pesquisa
1.
Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis.
Headache
; 63(6): 730-742, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37313616
2.
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
Headache
; 62(5): 624-633, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35593783
3.
Efficacy of erenumab in chronic migraine patients with and without ictal allodynia.
Cephalalgia
; 41(11-12): 1152-1160, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33982623
4.
Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension.
Cephalalgia
; 41(1): 6-16, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33269951
5.
Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial.
Eur J Neurol
; 28(5): 1716-1725, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400330
6.
Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine.
Headache
; 61(4): 653-661, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764538
7.
Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study.
Headache
; 61(6): 927-935, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153117
8.
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial.
J Headache Pain
; 22(1): 110, 2021 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537006
9.
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.
J Headache Pain
; 22(1): 81, 2021 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301173
10.
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
Cephalalgia
; 40(6): 543-553, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32216456
11.
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response.
Cephalalgia
; 40(1): 28-38, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31816249
12.
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism.
Nephrol Dial Transplant
; 35(10): 1769-1778, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30859218
13.
Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine.
Cephalalgia
; 39(11): 1455-1464, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31146544
14.
A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults.
Headache
; 59(10): 1731-1742, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31612482
15.
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
Cephalalgia
; 38(10): 1611-1621, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29984601
16.
Early onset of efficacy with erenumab in patients with episodic and chronic migraine.
J Headache Pain
; 19(1): 92, 2018 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30276500
17.
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
JAMA
; 317(2): 156-164, 2017 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097356
18.
Treatment of anemia with darbepoetin alfa in systolic heart failure.
N Engl J Med
; 368(13): 1210-9, 2013 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23473338
19.
Erratum.
Nephrol Dial Transplant
; : 1642, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31093680
20.
Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial.
BMJ Open
; 13(8): e068616, 2023 08 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37597868